The Heparin Anti-Xa test is a specialized blood test designed to monitor and adjust the dosage of heparin, a medication widely used as an anticoagulant to prevent and treat blood clots. This test measures the activity of heparin in the blood by evaluating its ability to inhibit factor Xa, a crucial component in the blood coagulation pathway. By assessing the anti-Xa activity, healthcare providers can ensure that the heparin dose is within the therapeutic range, optimizing its effectiveness while minimizing the risk of bleeding complications or clot formation.
At DNA Labs UAE, the cost for the Heparin Anti-Xa test is set at 1830 AED. DNA Labs UAE is equipped with state-of-the-art facilities and employs highly skilled professionals to conduct this test, ensuring accurate and reliable results. This test is particularly important for patients undergoing high-dose heparin therapy, such as those with deep vein thrombosis, pulmonary embolism, or those undergoing certain types of surgery where the risk of blood clots is higher. By providing precise monitoring, the Heparin Anti-Xa test plays a vital role in the management and treatment of conditions requiring anticoagulation therapy.
The Hepatitis B Monitoring Panel Test is a comprehensive diagnostic tool used to assess the presence and progression of Hepatitis B infection, a potentially life-threatening liver infection caused by the Hepatitis B virus (HBV). This panel typically includes a series of blood tests designed to evaluate various aspects of the virus and the body's response to it. These may include the measurement of HBV DNA levels to assess viral load, tests for hepatitis B surface antigen (HBsAg) and e-antigen (HBeAg) to determine infectivity, and tests for antibodies that indicate immune response or recovery.
Offered at DNA Labs UAE, a leading facility known for its advanced diagnostic technologies and expert medical staff, the Hepatitis B Monitoring Panel Test is priced at 1830 AED. The test is crucial for individuals diagnosed with or suspected of having Hepatitis B, as it helps in guiding treatment decisions, monitoring the effectiveness of therapy, and assessing the risk of disease progression to more severe conditions like cirrhosis or liver cancer. By providing a detailed view of the infection's status, the test plays a vital role in the management and control of Hepatitis B, ultimately contributing to better patient outcomes.
The Imatinib Resistance Mutation Analysis (IRMA) Test is a specialized diagnostic procedure designed to identify specific genetic mutations associated with resistance to Imatinib, a medication commonly used in the treatment of certain types of cancer, such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). Imatinib targets and inhibits specific tyrosine kinase enzymes, which are involved in the proliferation of cancer cells. However, mutations in the genes encoding these enzymes can lead to resistance against the drug, rendering it less effective or ineffective.
The IRMA Test is crucial for patients undergoing treatment with Imatinib or those for whom the treatment is being considered. By detecting mutations, the test helps in guiding clinicians to make informed decisions regarding the use of alternative therapies or adjustments in the treatment regimen, thereby optimizing patient outcomes.
Performed at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing services, the IRMA Test is offered at a cost of 1830 AED. The lab employs cutting-edge technology and methodologies to ensure accurate and reliable results, providing essential insights into the genetic profile of the cancer and its potential resistance to Imatinib. This personalized approach to cancer treatment underscores the importance of genetic testing in the era of precision medicine, where treatments can be tailored to the individual characteristics of each patient's disease.
The "Bromide Total Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to accurately measure the total concentration of bromide ions in the body. This test is particularly important for individuals who are exposed to bromide through various sources, such as certain medications, contaminated food or water, and industrial chemicals. Bromide, being a halide ion similar to chloride, can accumulate in the body and potentially disrupt normal bodily functions, making this test crucial for diagnosing and preventing related health issues.
The procedure involves a comprehensive analysis of the patient's blood or urine sample to detect and quantify the levels of bromide. Utilizing state-of-the-art technology and methodologies, DNA Labs UAE ensures precise and reliable results, which are critical for the effective management and treatment of conditions associated with abnormal bromide levels.
The cost of the Bromide Total Test at DNA Labs UAE is set at 1920 AED. This price reflects the sophisticated nature of the test and the expertise required to interpret the results accurately. Patients opting for this test at DNA Labs UAE can expect professional service, detailed analysis, and thorough explanation of their test results, aiding them in better understanding their health condition and necessary steps to take thereafter.
The Mesoridazine Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to monitor and measure the levels of mesoridazine in a patient's blood. Mesoridazine, an antipsychotic medication used for the treatment of schizophrenia and other mental health disorders, requires careful dosage management to ensure therapeutic effectiveness while minimizing potential side effects. The test plays a crucial role in the therapeutic drug monitoring (TDM) of patients on mesoridazine, aiding healthcare providers in adjusting dosages for optimal outcomes.
Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures accuracy and reliability in results, thanks to the lab's adherence to stringent quality standards. The cost of the Mesoridazine Test is set at 1900 AED, reflecting the comprehensive approach taken in the analysis, including the use of advanced technology and the expertise of skilled professionals in the field. This test is particularly important for patients undergoing treatment with mesoridazine, as it helps in preventing underdosing or overdosing, thereby contributing to more effective and safer treatment protocols.
The "AML Categorization PCR Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify specific genetic mutations associated with Acute Myeloid Leukemia (AML). By utilizing the Polymerase Chain Reaction (PCR) technology, this test amplifies and examines segments of DNA to pinpoint mutations that can influence treatment decisions and prognosis for AML patients. The cost of the test is set at 1900 AED, making it a valuable tool for both patients and healthcare providers in the United Arab Emirates for the effective management and treatment of AML. This precise and targeted approach aids in categorizing the type of AML, enabling personalized treatment plans that can significantly improve patient outcomes.
The CA 27.29 and CA 15.3 Breast Cancer Markers Panel Test is a crucial diagnostic tool used in the monitoring and management of individuals with breast cancer. This test measures the levels of two tumor markers, CA 27.29 and CA 15.3, which are substances often found in higher concentrations in the blood of individuals who have breast cancer. These markers can be elevated in the presence of breast cancer and may indicate the progression or recurrence of the disease.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The cost of the CA 27.29 and CA 15.3 Breast Cancer Markers Panel Test at DNA Labs UAE is 1870 AED. This test is particularly valuable for those undergoing treatment for breast cancer, as it helps healthcare providers assess the effectiveness of treatment and monitor for any signs of cancer recurrence. It is important to note that while this test can provide critical information about breast cancer status, it is typically used in conjunction with other diagnostic methods for a comprehensive evaluation.
Chimerism Split Cell Analysis, specifically the B Cell CD19 Test, is an advanced diagnostic procedure available at DNA Labs UAE, designed to monitor chimerism levels in patients who have undergone hematopoietic stem cell transplantation (HSCT). This test focuses on the CD19 marker, a protein expressed on the surface of B cells, which are a type of white blood cell crucial for the immune response. By analyzing the proportion of donor and recipient cells in the patient's blood, the B Cell CD19 Test provides valuable insights into the success of the transplantation, the risk of graft-versus-host disease (GVHD), and the patient's overall immune reconstitution.
The test is priced at 1870 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, which is known for its cutting-edge technology and highly qualified staff. This specific analysis is vital for post-transplant care, allowing healthcare providers to tailor treatment plans effectively and monitor patients' progress closely.
Chimerism Split Cell Analysis, specifically focusing on Myeloid Cell CD15 testing, is a specialized diagnostic procedure aimed at identifying the presence of two or more genetically distinct cell populations within an individual, often as a result of bone marrow or stem cell transplantation. This test is particularly critical in monitoring and assessing the success of transplant procedures, ensuring that the donor cells are effectively engrafting and replacing the recipient's original cells.
The CD15 marker is predominantly found on the surface of myeloid cells, which include neutrophils, eosinophils, and monocytes - key components of the immune system. By analyzing these cells for chimerism, medical professionals can gain valuable insights into the patient's post-transplant recovery process, including the detection of potential graft-versus-host disease (GVHD) or graft rejection early on.
Conducted at DNA Labs UAE, this test is meticulously designed to provide accurate and crucial information regarding the engraftment status and immune system health post-transplant. The cost of the Myeloid Cell CD15 Test is set at 1870 AED, reflecting the sophisticated nature of the analysis and the invaluable data it offers in guiding patient care and treatment plans.
Chimerism Split Cell Analysis, particularly focusing on the T Cell CD3 Test, is a sophisticated diagnostic procedure available at DNA Labs UAE. This test, costing 1870 AED, is designed to assess the presence and extent of chimerism in individuals who have undergone allogeneic stem cell transplantation. By isolating and analyzing T cells, specifically looking at the CD3 marker—a core component of the T-cell receptor complex on T lymphocytes—this test provides critical insights into the patient's immune system status and the success of the stem cell transplant.
The procedure is crucial for monitoring and managing post-transplant patients, as it helps in identifying graft-versus-host disease (GVHD) risks, guiding immunosuppressive therapy, and detecting potential transplant rejection early. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test leverages advanced molecular techniques to deliver precise and reliable results, playing a vital role in the post-transplant care and overall patient management strategy.
